chronic liver disease

A new CDC report reveals surprising and disturbing findings regarding overall death rates in America. They were found to have risen last year, albeit slightly, as compared to the year before. The cause, or causes, of this upturn are unknown, but should be pursued.
A protein involved in pathological angiogenesis can serve as a new therapeutic target in the treatment of chronic liver disease, which claims nearly 50,000 lives annually. In vivo tests involving knock-out mice has shown promising results.